Michael Tribanek

484 total citations
8 papers, 238 citations indexed

About

Michael Tribanek is a scholar working on Complementary and alternative medicine, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Michael Tribanek has authored 8 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Complementary and alternative medicine, 4 papers in Neurology and 4 papers in Psychiatry and Mental health. Recurrent topics in Michael Tribanek's work include Dementia and Cognitive Impairment Research (4 papers), Neurological Disease Mechanisms and Treatments (4 papers) and Ginkgo biloba and Cashew Applications (4 papers). Michael Tribanek is often cited by papers focused on Dementia and Cognitive Impairment Research (4 papers), Neurological Disease Mechanisms and Treatments (4 papers) and Ginkgo biloba and Cashew Applications (4 papers). Michael Tribanek collaborates with scholars based in Germany, Ukraine and United States. Michael Tribanek's co-authors include Ralf Ihl, N. Bachinskaya, Robert Hoerr, Oleksandr Napryeyenko, Amos D. Korczyn, Veronika Vakhapova, Meinhard Kieser, H Matthys, Jeffrey L. Cummings and H. Herrschaft and has published in prestigious journals such as Journal of the Neurological Sciences, Alzheimer s & Dementia and International Journal of Geriatric Psychiatry.

In The Last Decade

Michael Tribanek

8 papers receiving 232 citations

Peers

Michael Tribanek
N. Bachinskaya Ukraine
R Hörr Germany
W Wierich Germany
Encarnita Ampil Philippines
Seyed Amir Hejazi Iran
Janet Cellar United States
Yue You China
Salvatore Putignano Italy
Ui Min Jerng South Korea
Chunlan Hong Germany
N. Bachinskaya Ukraine
Michael Tribanek
Citations per year, relative to Michael Tribanek Michael Tribanek (= 1×) peers N. Bachinskaya

Countries citing papers authored by Michael Tribanek

Since Specialization
Citations

This map shows the geographic impact of Michael Tribanek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Tribanek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Tribanek more than expected).

Fields of papers citing papers by Michael Tribanek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Tribanek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Tribanek. The network helps show where Michael Tribanek may publish in the future.

Co-authorship network of co-authors of Michael Tribanek

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Tribanek. A scholar is included among the top collaborators of Michael Tribanek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Tribanek. Michael Tribanek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Cummings, Jeffrey L., Michael Tribanek, & Robert Hoerr. (2014). Sensitivity to change of composite and frequency scores of the neuropsychiatric inventory in mild cognitive impairment. International Psychogeriatrics. 26(11). 1871–1874. 4 indexed citations
2.
Matthys, H, et al.. (2013). Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD. Respiratory Medicine. 107(5). 691–701. 20 indexed citations
3.
Cummings, Jeffrey L., Ralf Ihl, H. Herrschaft, Robert Hoerr, & Michael Tribanek. (2012). Sensitivity to change of composite and frequency scores of the Neuropsychiatric Inventory in mild to moderate dementia. International Psychogeriatrics. 25(3). 431–438. 10 indexed citations
4.
5.
Ihl, Ralf, N. Bachinskaya, Amos D. Korczyn, et al.. (2010). Efficacy and safety of a once‐daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. International Journal of Geriatric Psychiatry. 26(11). 1186–1194. 98 indexed citations
6.
7.
Matthys, H, et al.. (2010). Add-on-therapy In COPD With An Herbal Drug Preparation. A4421–A4421. 1 indexed citations
8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Bachinskaya Breakdown of academic impact, for papers by R Hörr Breakdown of academic impact, for papers by W Wierich Breakdown of academic impact, for papers by Encarnita Ampil Breakdown of academic impact, for papers by Seyed Amir Hejazi Breakdown of academic impact, for papers by Janet Cellar Breakdown of academic impact, for papers by Yue You Breakdown of academic impact, for papers by Salvatore Putignano Breakdown of academic impact, for papers by Ui Min Jerng Breakdown of academic impact, for papers by Chunlan Hong
Rankless by CCL
2026